In acute promyelocytic leukemia (APL), treatment with all-trans retinoic acid (ATRA) reverses promyelocytic leukemia-retinoic acid receptor α (PML-RARα)-mediated differentiation block at the promyelocyte stage resulting in mature neutrophil-like cells (41, 42). Here, RARA is linked to acute promyelocytic leukemia.